Propionate and butyrate counteract renal damage and progression to chronic kidney disease
Short-chain fatty acids (SCFAs), mainly acetate, propionate and butyrate, are produced by gut microbiota through fermentation of complex carbohydrates that cannot be digested by the human host. They affect gut health and can contribute at the distal level to the pathophysiology of several diseases,...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/381940 |
| Acceso en línea: | http://hdl.handle.net/10261/381940 https://api.elsevier.com/content/abstract/scopus_id/85210573436 |
| Access Level: | acceso abierto |
| Palabra clave: | AKI-to-CKD transition Acute kidney injury Fibrosis Inflammation Short-chain fatty acids |
| Sumario: | Short-chain fatty acids (SCFAs), mainly acetate, propionate and butyrate, are produced by gut microbiota through fermentation of complex carbohydrates that cannot be digested by the human host. They affect gut health and can contribute at the distal level to the pathophysiology of several diseases, including renal pathologies. |
|---|